Oncocyte Corp·4

Mar 15, 4:19 PM ET

Levine Mitchell S 4

4 · Oncocyte Corp · Filed Mar 15, 2022

Insider Transaction Report

Form 4
Period: 2022-03-15
Levine Mitchell S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, no par value

    2022-03-15$1.17/sh+25,000$29,15087,080 total
Footnotes (1)
  • [F1]The price of $1.166 per share represents a weighted average of prices ranging from $1.155 to $1.180 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary